Wall Street Zen cut shares of ASP Isotopes (NASDAQ:ASPI – Free Report) from a sell rating to a strong sell rating in a research report released on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, September 21st. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $12.00.
Get Our Latest Analysis on ASPI
ASP Isotopes Stock Performance
ASP Isotopes stock opened at $1.10 on Friday. The company has a market cap of $168.64 million, a PE ratio of -0.80 and a beta of 3.77. The company has a current ratio of 3.44, a quick ratio of 3.85 and a debt-to-equity ratio of 0.25. ASP Isotopes has a 1 year low of $1.03 and a 1 year high of $8.60. The company’s 50-day moving average is $2.32 and its two-hundred day moving average is $4.45.
Insider Buying and Selling
In related news, COO Robert Ainscow sold 67,500 shares of the company’s stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $1.57, for a total value of $105,975.00. Following the completion of the sale, the chief operating officer owned 2,158,441 shares in the company, valued at approximately $3,388,752.37. This represents a 3.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Mann sold 83,759 shares of the company’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $4.10, for a total value of $343,411.90. Following the completion of the sale, the chief executive officer owned 9,328,570 shares of the company’s stock, valued at $38,247,137. This represents a 0.89% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 312,785 shares of company stock valued at $1,005,862 over the last 90 days. Company insiders own 14.40% of the company’s stock.
Hedge Funds Weigh In On ASP Isotopes
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company increased its stake in shares of ASP Isotopes by 8.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock valued at $135,000 after acquiring an additional 2,470 shares during the last quarter. Sanctuary Advisors LLC boosted its stake in ASP Isotopes by 22.2% during the 1st quarter. Sanctuary Advisors LLC now owns 24,615 shares of the company’s stock worth $109,000 after acquiring an additional 4,465 shares during the last quarter. Voya Investment Management LLC boosted its stake in ASP Isotopes by 24.3% during the 3rd quarter. Voya Investment Management LLC now owns 27,468 shares of the company’s stock worth $73,000 after acquiring an additional 5,377 shares during the last quarter. Royal Bank of Canada boosted its stake in ASP Isotopes by 18.4% during the 1st quarter. Royal Bank of Canada now owns 37,954 shares of the company’s stock worth $167,000 after acquiring an additional 5,906 shares during the last quarter. Finally, State of Wyoming acquired a new position in ASP Isotopes during the first quarter valued at approximately $29,000. Institutional investors own 16.80% of the company’s stock.
About ASP Isotopes
ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.
Further Reading
- Five stocks we like better than ASP Isotopes
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
